Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 58.68% is in line with its 5-year average of 57.42%, near the high end of its 5-year range (56.02%–59.43%).
As of the fiscal period ended Tuesday, March 31, 2026. 1.63% above its 12-month average of 57.74%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
58.68%
GROSS MARGIN AVG TTM
57.74%
GROSS MARGIN AVG 3Y
57.57%
GROSS MARGIN AVG 5Y
57.31%
GROSS MARGIN AVG 10Y
56.80%
GROSS MARGIN AVG 15Y
55.91%
GROSS MARGIN AVG 20Y
54.63%
CURRENT VS TTM AVG
+1.63%
CURRENT VS 3Y AVG
+1.93%
CURRENT VS 5Y AVG
+2.39%
CURRENT VS 10Y AVG
+3.33%
CURRENT VS 15Y AVG
+4.97%
CURRENT VS 20Y AVG
+7.42%
SECTOR MEDIAN · HEALTHCARE
58.51%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+0.30%
vs the sector median at left
Mettler-Toledo International Inc.
Market Cap
$26.82B
Gross Margin
58.68%
TTM Avg
57.74%
3Y Avg
57.57%
5Y Avg
57.31%
Market Cap
$27.56B
Gross Margin
42.55%
TTM Avg
40.85%
3Y Avg
40.34%
5Y Avg
40.27%
Market Cap
$25.15B
Gross Margin
33.15%
TTM Avg
32.39%
3Y Avg
33.17%
5Y Avg
35.04%
Market Cap
$24.34B
Gross Margin
27.79%
TTM Avg
27.30%
3Y Avg
28.39%
5Y Avg
31.16%
Market Cap
$23.51B
Gross Margin
92.48%
TTM Avg
92.70%
3Y Avg
93.10%
5Y Avg
93.74%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mettler-Toledo International Inc. (MTD) | $26.82B | 58.68% | 57.74% | 57.57% | 57.31% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $27.56B | 42.55% | 40.85% | 40.34% | 40.27% |
| DexCom, Inc. (DXCM)vs › | $27.61B | 61.84% | 60.23% | 62.09% | 63.91% |
| ResMed Inc. (RMD)vs › | $28.33B | 61.69% | 58.02% | 57.09% | 57.33% |
| Quest Diagnostics Incorporated (DGX)vs › | $25.15B | 33.15% | 32.39% | 33.17% | 35.04% |
| Waters Corporation (WAT)vs › | $24.42B | 55.02% | 58.60% | 58.69% | 58.45% |
| Labcorp Holdings Inc. (LH)vs › | $24.34B | 27.79% | 27.30% | 28.39% | 31.16% |
| Biogen Inc. (BIIB)vs › | $29.85B | 69.77% | 73.30% | 74.61% | 77.63% |
| Incyte Corporation (INCY)vs › | $23.51B | 92.48% | 92.70% | 93.10% | 93.74% |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.10B | 36.77% | 35.27% | 37.10% | 37.60% |
Gross Margin
58.7%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-03-31 | 58.68% |
| 2025-12-31 | 58.05% |
| 2025-09-30 | 57.24% |
| 2025-06-30 | 57.19% |
| 2025-03-31 | 57.56% |
| 2024-12-31 | 59.43% |
| 2024-09-30 | 58.06% |
| 2024-06-30 | 57.83% |
| 2024-03-31 | 57.23% |
| 2023-12-31 | 57.07% |
| 2023-09-30 | 57.43% |
| 2023-06-30 | 57.58% |
| 2023-03-31 | 56.94% |
| 2022-12-31 | 58.20% |
| 2022-09-30 | 57.61% |
| 2022-06-30 | 56.76% |
| 2022-03-31 | 56.02% |
| 2021-12-31 | 56.90% |
| 2021-09-30 | 56.70% |
| 2021-06-30 | 56.33% |
| 2021-03-31 | 56.91% |
| 2020-12-31 | 58.04% |
| 2020-09-30 | 56.42% |
| 2020-06-30 | 55.61% |
| 2020-03-31 | 55.52% |
| 2019-12-31 | 57.52% |
| 2019-09-30 | 56.07% |
| 2019-06-30 | 55.68% |
| 2019-03-31 | 55.35% |
| 2018-12-31 | 56.93% |
| 2018-09-30 | 55.44% |
| 2018-06-30 | 55.49% |
| 2018-03-31 | 54.96% |
| 2017-12-31 | 57.01% |
| 2017-09-30 | 55.85% |
| 2017-06-30 | 55.90% |
| 2017-03-31 | 55.98% |
| 2016-12-31 | 57.28% |
| 2016-09-30 | 55.15% |
| 2016-06-30 | 57.14% |
| 2016-03-31 | 55.57% |
| 2015-12-31 | 58.01% |
| 2015-09-30 | 56.20% |
| 2015-06-30 | 55.48% |
| 2015-03-31 | 55.78% |
| 2014-12-31 | 56.55% |
| 2014-09-30 | 54.61% |
| 2014-06-30 | 53.90% |
| 2014-03-31 | 53.15% |
| 2013-12-31 | 54.86% |
| 2013-09-30 | 53.84% |
| 2013-06-30 | 53.37% |
| 2013-03-31 | 53.26% |
| 2012-12-31 | 54.28% |
| 2012-09-30 | 53.26% |
| 2012-06-30 | 52.43% |
| 2012-03-31 | 51.76% |
| 2011-12-31 | 53.39% |
| 2011-09-30 | 52.31% |
| 2011-06-30 | 52.79% |
| 2011-03-31 | 52.43% |
| 2010-12-31 | 53.41% |
| 2010-09-30 | 52.23% |
| 2010-06-30 | 52.64% |
| 2010-03-31 | 52.30% |
| 2009-12-31 | 52.76% |
| 2009-09-30 | 51.69% |
| 2009-06-30 | 50.62% |
| 2009-03-31 | 50.24% |
| 2008-12-31 | 51.84% |
| 2008-09-30 | 48.85% |
| 2008-06-30 | 50.23% |
| 2008-03-31 | 50.38% |
| 2007-12-31 | 50.78% |
| 2007-09-30 | 49.48% |
| 2007-06-30 | 49.96% |
| 2007-03-31 | 49.38% |
| 2006-12-31 | 50.53% |
| 2006-09-30 | 48.84% |
| 2006-06-30 | 49.45% |
| 2006-03-31 | 49.21% |
| 2005-12-31 | 50.60% |
| 2005-09-30 | 48.99% |
| 2005-06-30 | 48.94% |
| 2005-03-31 | 48.28% |
| 2004-12-31 | 49.71% |
| 2004-09-30 | 48.46% |
| 2004-06-30 | 48.74% |
| 2004-03-31 | 47.15% |
| 2003-12-31 | 47.58% |
| 2003-09-30 | 47.34% |
| 2003-06-30 | 48.67% |
| 2003-03-31 | 45.80% |
| 2002-12-31 | 47.02% |
| 2002-09-30 | 46.56% |
| 2002-06-30 | 47.59% |
